CYTOSORBENTS CORPORATION Unrecognized Tax Benefits, Period Increase (Decrease)
CYTOSORBENTS CORPORATION (CTSO) reported Unrecognized Tax Benefits, Period Increase (Decrease) of -$120.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2026-03-30
- CYTOSORBENTS CORPORATION unrecognized tax benefits, period increase (decrease) for fiscal 2025 was -$120.00K.
- CYTOSORBENTS CORPORATION unrecognized tax benefits, period increase (decrease) for fiscal 2024 was -$9.00K, a 100.57% decline from fiscal 2023.
- CYTOSORBENTS CORPORATION unrecognized tax benefits, period increase (decrease) for fiscal 2023 was $1.57M.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$120.00K 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$9.00K 10-K · filed 2026-03-30 | -$9.28K 10-K · filed 2025-03-31 |
| 2023-12-31 | $1.57M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |